Evidence map›Paper›PMID 35779538›Full record

ArticleThe Lancet. Public health2022

The role of low-income and middle-income country prisons in eliminating hepatitis C.

Matthew J Akiyama, Nadine Kronfli, Joaquin Cabezas, Yumi Sheehan, Andrew Scheibe, Taha Brahni, Kunal Naik, Pelmos Mashabela, Polin Chan, Niklas Luhmann and 2 more

Abstract read
In one paragraph

Article in The Lancet. Public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Matthew J AkiyamaDepartment of Medicine, Divisions of General Internal Medicine and Infectious Diseases, Albert Einstein College of Medicine/Montefiore Medical Center, New York 10467, NY, USA. Electronic address: makiyama@montefiore.org.
Nadine KronfliDepartment of Medicine, Division of Infectious Diseases and Chronic Viral Illness Service, McGill University, Montreal, QC, Canada.
Joaquin CabezasGastroenterology and Hepatology Department, Marqués de Valdecilla University Hospital, Santander, Spain; Valdecilla Biomedical Research Institute (IDIVAL), Santander, Spain.
Yumi SheehanViral Immunology Systems Program, Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
Andrew ScheibeTB HIV Care, Cape Town, South Africa; Community Oriented Primary Care research unit, Department of Family Medicine, University of Pretoria, Pretoria, South Africa.
Taha BrahniAssociation de Lutte Contre le Sida, Casablanca, Morocco.
Kunal NaikPrévention Information et Lutte Contre le SIDA, Port Louis, Mauritius.
Pelmos MashabelaNational Department of Correctional Services, Pretoria, South Africa.
Polin ChanWHO Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, WHO, Geneva, Switzerland.
Niklas LuhmannWHO Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, WHO, Geneva, Switzerland.
Andrew R LloydViral Immunology Systems Program, Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
International Network on Health and Hepatitis in Substance Users—Prisons Network (INHSU Prisons)

Funding

World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis CPrisonsHumansIncomePoverty

Identifiers

PMID35779538
PMCPMC9253889

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.